Celldex Therapeutics | CLDX - L'Utile Operativo

Prezzo Delle Azioni
33.89
Cambio Giornaliero
0.03 0.09%
Mensile
8.03%
Annuale
84.18%
Q2 Previsione
31.64




L'Utile Operativo Cambiamento Data
AbbVie USD 4.73B 1.08B 2026-03
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Northwest Biotherapeutics USD -14.32M 481K 2025-09
Pfizer USD 4.99B 340M 2026-03
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12